Sex Hormone Metabolism in Prostate Cancer Cells during Transition to an Androgen-Independent State

The Physiology of Reproduction

1988 • 7,765 citations

Cloning of a novel receptor expressed in rat prostate and ovary.

1996 • 4,782 citations

Cancer Statistics, 2001

2001 • 3,342 citations

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1941 • 3,235 citations

LNCaP model of human prostatic carcinoma.

1983 • 1,749 citations

A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

1989 • 1,494 citations

Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death

1998 • 640 citations

Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3

1994 • 561 citations

The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element

1991 • 452 citations

Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity

1993 • 433 citations

Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis

2000 • 310 citations

17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes

1999 • 297 citations

Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin

1992 • 266 citations

Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1

1999 • 255 citations

Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

2001 • 242 citations

Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase

2001 • 240 citations

Tissue-specific and hormonal regulations of human prostate-specific glandular kallikrein

1992 • 187 citations

Molecular Genetics and Epidemiology of Prostate Carcinoma

1999 • 182 citations

Androgen Regulation of Programmed Death of Normal and Malignant Prostatic Cells

1992 • 168 citations

Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.

1992 • 166 citations

Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression

2000 • 113 citations

Science behind total androgen blockade: from gene to combination therapy.

1993 • 100 citations

Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.

1997 • 96 citations

Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)

2001 • 91 citations

Transcriptional regulation of prostate kallikrein-like genes by androgen.

1992 • 91 citations

Tissue-type plasminogen activator, a new prognostic marker in breast cancer.

1988 • 88 citations

Human 17β-Hydroxysteroid Dehydrogenase Type 2 Messenger Ribonucleic Acid Expression and Localization in Term Placenta and in Endometrium during the Menstrual Cycle¹

1998 • 85 citations

Estrogen Receptor β in Prostate Cancer

2001 • 84 citations

Nuclei of stroma: Site of highest estrogen concentration in human benign prostatic hyperplasia

1982 • 80 citations

17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin.

1992 • 77 citations

Expression and Localization of Activin Subunits and Follistatins in Tissues from Men with High Grade Prostate Cancer

1997 • 75 citations

Intratissular androgens in benign prostatic hyperplasia and prostatic cancer

1986 • 73 citations

Origin of Substrate Specificity of Human and Rat 17β-Hydroxysteroid Dehydrogenase Type 1, Using Chimeric Enzymes and Site-Directed Substitutions*

1997 • 70 citations

Characterization of 17B‐hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate

1996 • 66 citations

Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells.

1993 • 62 citations

Prostate cancer progression. Implications of histopathology.

1994 • 61 citations

Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1–q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient

1998 • 55 citations

Characterization of Molecular and Catalytic Properties of Intact and Truncated Human 17β-Hydroxysteroid Dehydrogenase Type 2 Enzymes: Intracellular Localization of the Wild-Type Enzyme in the Endoplasmic Reticulum*

1999 • 53 citations

Regulation of estrogen action: role of 17 beta-hydroxysteroid dehydrogenases.

1999 • 50 citations

Regulation of Oestrogen Action: Role of 17β-hydroxysteroid Dehydrogenases

1995 • 48 citations

Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization.

1993 • 47 citations

Downregulation of estrogen‐metabolizing 17β‐hydroxysteroid dehydrogenase Type 2 expression correlates inversely with Ki67 proliferation marker in colon‐cancer development

2001 • 42 citations

Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer

2001 • 17 citations

Analysis of fibrinolytic proteins in relation to DNA ploidy in prostate cancer

1998 • 15 citations